Loading...

Anne Louise Peters, MD

Title(s)Professor of Clinical Medicine
Phone+1 310 657 3030
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Association for the Advancement of Science1974Research Award
    1980National Institutes of Health Summer Research Award
    American Medical Women's Association1983Citation for Scholastic Achievement
    American College of Physicians1991Fellow
    Cedars-Sinai Medical Center1991Morris Press Humanism Award
    2001  - 2004Best Doctors in America
    Diabetes Management Clinic2004Honorable Mention
    2004Safety Net Award
    American Diabetes Association2008Outstanding Physician Clinician Award
    National Minority Quality Forum2010Bernardo Alberto Houssay Award

    Collapse Overview 
    Collapse Overview
    Anne Peters, M.D., is Professor of Medicine at the Keck School of Medicine of USC and Director of the USC Clinical Diabetes Programs. Dr. Peters earned her medical degree from the Pritzker School of Medicine at the University of Chicago and performed an internal medicine residency at Stanford University and an endocrinology fellowship at Cedars-Sinai Medical Center. She previously directed the clinical diabetes programs at Cedars-Sinai and UCLA. Her research has focused on testing new approaches for diagnosing and treating diabetes and developing systems of care to improve outcomes in diabetic populations.

    She has published over 200 articles, reviews, and abstracts and three books on diabetes. She has been an investigator on over 40 research studies and has spoken at over 400 programs throughout the US as well as internationally. She has served on many committees for the ADA and other organizations. Currently she is the chair of the Endocrine Society Committee on Diabetes Devices and is on the EASD/ADA Technology Safety Committee. Additionally she is a member of the JDRF Panel on Management of Exercise in Type 1 Diabetes. She is a member of the ABIM Endocrinology Subspecialty Board. She consults for many entities, including the FDA, Optum Rx and CVS/Caremark to help guide the development and use of treatments for diabetes.

    Collapse Research 
    Collapse Research Activities and Funding
    15/16 Action for Health in Diabetes Extension Study Research Project
    NIH/NIDDK U01DK057219Sep 30, 1999 - Jan 31, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cohan P, East HE, Galati SJ, Mercado JU, Lim PJ, Lamerson M, Smith JJ, Peters AL, Yuen KCJ. Mifepristone Treatment in Four Cases of Primary Bilateral Macronodular Adrenal Hyperplasia (BMAH). J Clin Endocrinol Metab. 2019 May 21. PMID: 31112270.
      View in: PubMed
    2. Alexopoulos AS, Blair R, Peters AL. Management of Preexisting Diabetes in Pregnancy: A Review. JAMA. 2019 05 14; 321(18):1811-1819. PMID: 31087027.
      View in: PubMed
    3. Peters AL, Piletic M, Ejstrud J, Salvesen-Sykes K, Snyder J, Bowering K. Baseline nocturnal glucose change: A predictor of the treatment effect of bolus intensification in insulin-treated type 2 diabetes. Diabetes Obes Metab. 2019 Jul; 21(7):1752-1756. PMID: 30924578.
      View in: PubMed
    4. Danne T, Cariou B, Buse JB, Garg SK, Rosenstock J, Banks P, Kushner JA, McGuire DK, Peters AL, Sawhney S, Strumph P. Improved Time in Range and Glycemic Variability With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of 24-Week Continuous Glucose Monitoring Data From the inTandem Program. Diabetes Care. 2019 May; 42(5):919-930. PMID: 30833371.
      View in: PubMed
    5. Danne T, Garg S, Peters AL, Buse JB, Mathieu C, Pettus JH, Alexander CM, Battelino T, Ampudia-Blasco FJ, Bode BW, Cariou B, Close KL, Dandona P, Dutta S, Ferrannini E, Fourlanos S, Grunberger G, Heller SR, Henry RR, Kurian MJ, Kushner JA, Oron T, Parkin CG, Pieber TR, Rodbard HW, Schatz D, Skyler JS, Tamborlane WV, Yokote K, Phillip M. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium-Glucose Cotransporter (SGLT) Inhibitors. Diabetes Care. 2019 Jun; 42(6):1147-1154. PMID: 30728224.
      View in: PubMed
    6. Peters AL. The Changing Definition of a Primary Care Provider. Ann Intern Med. 2018 Dec 18; 169(12):875-876. PMID: 30458467.
      View in: PubMed
    7. Vigen CLP, Carandang K, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL, Pyatak EA. Psychosocial and Behavioral Correlates of A1C and Quality of Life Among Young Adults With Diabetes. Diabetes Educ. 2018 12; 44(6):489-500. PMID: 30295170.
      View in: PubMed
    8. Peters AL, Ahmann AJ, Hirsch IB, Raymond JK. Advances in Glucose Monitoring and Automated Insulin Delivery: Supplement to Endocrine Society Clinical Practice Guidelines. J Endocr Soc. 2018 Nov 01; 2(11):1214-1225. PMID: 30324178.
      View in: PubMed
    9. Akturk HK, Snell-Bergeon JK, Rewers A, Klaff LJ, Bode BW, Peters AL, Bailey TS, Garg SK. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study. Diabetes Technol Ther. 2018 10; 20(10):639-647. PMID: 30207748.
      View in: PubMed
    10. Garg SK, Peters AL, Buse JB, Danne T. Strategy for Mitigating DKA Risk in Patients with Type 1 Diabetes on Adjunctive Treatment with SGLT Inhibitors: A STICH Protocol. Diabetes Technol Ther. 2018 09; 20(9):571-575. PMID: 30129772.
      View in: PubMed
    11. Polsky S, Wu M, Bode BW, DuBose SN, Goland RS, Maahs DM, Foster NC, Peters AL, Levy CJ, Shah VN, Beck RW. Diabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange. Diabetes Technol Ther. 2018 08; 20(8):517-523. PMID: 29990438.
      View in: PubMed
    12. Fisher L, Hessler D, Polonsky WH, Masharani U, Guzman S, Bowyer V, Strycker L, Ahmann A, Basina M, Blumer I, Chloe C, Kim S, Peters AL, Shumway M, Weihs K, Wu P. T1-REDEEM: A Randomized Controlled Trial to Reduce Diabetes Distress Among Adults With Type 1 Diabetes. Diabetes Care. 2018 09; 41(9):1862-1869. PMID: 29976567.
      View in: PubMed
    13. Buse JB, Garg SK, Rosenstock J, Bailey TS, Banks P, Bode BW, Danne T, Kushner JA, Lane WS, Lapuerta P, McGuire DK, Peters AL, Reed J, Sawhney S, Strumph P. Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study. Diabetes Care. 2018 Sep; 41(9):1970-1980. PMID: 29937430.
      View in: PubMed
    14. Danne T, Cariou B, Banks P, Brandle M, Brath H, Franek E, Kushner JA, Lapuerta P, McGuire DK, Peters AL, Sawhney S, Strumph P. HbA1c and Hypoglycemia Reductions at 24 and 52 Weeks With Sotagliflozin in Combination With Insulin in Adults With Type 1 Diabetes: The European inTandem2 Study. Diabetes Care. 2018 Sep; 41(9):1981-1990. PMID: 29937431.
      View in: PubMed
    15. Peters AL. A Physician's Place in the #MeToo Movement. Ann Intern Med. 2018 May 01; 168(9):676-677. PMID: 29710264.
      View in: PubMed
    16. Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS. Author Correction: Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018 Apr; 9(2):613-621. PMID: 29508274.
      View in: PubMed
    17. Gregg EW, Lin J, Bardenheier B, Chen H, Rejeski WJ, Zhuo X, Hergenroeder AL, Kritchevsky SB, Peters AL, Wagenknecht LE, Ip EH, Espeland MA. Impact of Intensive Lifestyle Intervention on Disability-Free Life Expectancy: The Look AHEAD Study. Diabetes Care. 2018 05; 41(5):1040-1048. PMID: 29545462.
      View in: PubMed
    18. Pozzilli P, Leslie RD, Peters AL, Buzzetti R, Shankar SS, Milicevic Z, Pavo I, Lebrec J, Martin S, Schloot NC. Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials. Diabetes Obes Metab. 2018 06; 20(6):1490-1498. PMID: 29377522.
      View in: PubMed
    19. Hallberg SJ, McKenzie AL, Williams PT, Bhanpuri NH, Peters AL, Campbell WW, Hazbun TL, Volk BM, McCarter JP, Phinney SD, Volek JS. Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study. Diabetes Ther. 2018 Apr; 9(2):583-612. PMID: 29417495.
      View in: PubMed
    20. Pyatak EA, Carandang K, Vigen CLP, Blanchard J, Diaz J, Concha-Chavez A, Sequeira PA, Wood JR, Whittemore R, Spruijt-Metz D, Peters AL. Occupational Therapy Intervention Improves Glycemic Control and Quality of Life Among Young Adults With Diabetes: the Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) Randomized Controlled Trial. Diabetes Care. 2018 04; 41(4):696-704. PMID: 29351961.
      View in: PubMed
    21. Petrie JR, Peters AL, Bergenstal RM, Holl RW, Fleming GA, Heinemann L. Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2017 12; 40(12):1614-1621. PMID: 29070577.
      View in: PubMed
    22. Peters AL. Rethinking Rates of Undiagnosed Diabetes: The Value of a Confirmatory Test. Ann Intern Med. 2017 12 05; 167(11):822-823. PMID: 29059685.
      View in: PubMed
    23. MacEwan JP, Sheehan JJ, Yin W, Vanderpuye-Orgle J, Sullivan J, Peneva D, Kalsekar I, Peters AL. The relationship between adherence and total spending among Medicare beneficiaries with type 2 diabetes. Am J Manag Care. 2017 Apr; 23(4):248-252. PMID: 28554205.
      View in: PubMed
    24. Aleppo G, Ruedy KJ, Riddlesworth TD, Kruger DF, Peters AL, Hirsch I, Bergenstal RM, Toschi E, Ahmann AJ, Shah VN, Rickels MR, Bode BW, Philis-Tsimikas A, Pop-Busui R, Rodriguez H, Eyth E, Bhargava A, Kollman C, Beck RW. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes. Diabetes Care. 2017 Apr; 40(4):538-545. PMID: 28209654.
      View in: PubMed
    25. Pyatak EA, Carandang K, Vigen C, Blanchard J, Sequeira PA, Wood JR, Spruijt-Metz D, Whittemore R, Peters AL. Resilient, Empowered, Active Living with Diabetes (REAL Diabetes) study: Methodology and baseline characteristics of a randomized controlled trial evaluating an occupation-based diabetes management intervention for young adults. Contemp Clin Trials. 2017 03; 54:8-17. PMID: 28064028.
      View in: PubMed
    26. Garvey KC, Foster NC, Agarwal S, DiMeglio LA, Anderson BJ, Corathers SD, Desimone ME, Libman IM, Lyons SK, Peters AL, Raymond JK, Laffel LM. Health Care Transition Preparation and Experiences in a U.S. National Sample of Young Adults With Type 1 Diabetes. Diabetes Care. 2017 Mar; 40(3):317-324. PMID: 28007779.
      View in: PubMed
    27. DuBose SN, Weinstock RS, Beck RW, Peters AL, Aleppo G, Bergenstal RM, Rodriguez H, Largay JF, Massaro EM, Hirsch IB. Hypoglycemia in Older Adults with Type 1 Diabetes. Diabetes Technol Ther. 2016 12; 18(12):765-771. PMID: 27996319.
      View in: PubMed
    28. Unick JL, Gaussoin SA, Hill JO, Jakicic JM, Bond DS, Hellgren M, Johnson KC, Peters AL, Coday M, Kitzman DW, Bossart S, Wing RR. Four-Year Physical Activity Levels among Intervention Participants with Type 2 Diabetes. Med Sci Sports Exerc. 2016 12; 48(12):2437-2445. PMID: 27471785.
      View in: PubMed
    29. Rodbard HW, Peters AL, Slee A, Cao A, Traina SB, Alba M. The Effect of Canagliflozin, a Sodium Glucose Cotransporter 2 Inhibitor, on Glycemic End Points Assessed by Continuous Glucose Monitoring and Patient-Reported Outcomes Among People With Type 1 Diabetes. Diabetes Care. 2017 Feb; 40(2):171-180. PMID: 27899497.
      View in: PubMed
    30. Pyatak EA, Sequeira PA, Vigen CL, Weigensberg MJ, Wood JR, Montoya L, Ruelas V, Peters AL. Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes. J Adolesc Health. 2017 Feb; 60(2):212-218. PMID: 27889401.
      View in: PubMed
    31. Chen F, Su W, Becker SH, Payne M, Castro Sweet CM, Peters AL, Dall TM. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease. PLoS One. 2016; 11(10):e0163627. PMID: 27706216.
      View in: PubMed
    32. Peters AL, Ahmann AJ, Battelino T, Evert A, Hirsch IB, Murad MH, Winter WE, Wolpert H. Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016 Nov; 101(11):3922-3937. PMID: 27588440.
      View in: PubMed
    33. Polonsky WH, Peters AL, Hessler D. The Impact of Real-Time Continuous Glucose Monitoring in Patients 65 Years and Older. J Diabetes Sci Technol. 2016 07; 10(4):892-7. PMID: 27022095.
      View in: PubMed
    34. Peters AL, Henry RR, Thakkar P, Tong C, Alba M. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes. Diabetes Care. 2016 Apr; 39(4):532-8. PMID: 26989182.
      View in: PubMed
    35. Weinstock RS, DuBose SN, Bergenstal RM, Chaytor NS, Peterson C, Olson BA, Munshi MN, Perrin AJ, Miller KM, Beck RW, Liljenquist DR, Aleppo G, Buse JB, Kruger D, Bhargava A, Goland RS, Edelen RC, Pratley RE, Peters AL, Rodriguez H, Ahmann AJ, Lock JP, Garg SK, Rickels MR, Hirsch IB. Risk Factors Associated With Severe Hypoglycemia in Older Adults With Type 1 Diabetes. Diabetes Care. 2016 Apr; 39(4):603-10. PMID: 26681721.
      View in: PubMed
    36. Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition. Diabetes Care. 2015 Sep; 38(9):1687-93. PMID: 26078479.
      View in: PubMed
    37. Sequeira PA, Pyatak EA, Weigensberg MJ, Vigen CP, Wood JR, Ruelas V, Montoya L, Cohen M, Speer H, Clark S, Peters AL. Let's Empower and Prepare (LEAP): Evaluation of a Structured Transition Program for Young Adults With Type 1 Diabetes. Diabetes Care. 2015 Aug; 38(8):1412-9. PMID: 25906787.
      View in: PubMed
    38. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S. Response to comment on Wong et al. Real-time continuous glucose monitoring among participants in the T1D exchange clinic registry. Diabetes Care 2014;37:2702-2709. Diabetes Care. 2015 Apr; 38(4):e61. PMID: 25805875.
      View in: PubMed
    39. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetes Care. 2015 Apr; 38(4):716-22. PMID: 25776138.
      View in: PubMed
    40. Heinemann L, Fleming GA, Petrie JR, Holl RW, Bergenstal RM, Peters AL. Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group. Diabetologia. 2015 May; 58(5):862-70. PMID: 25784563.
      View in: PubMed
    41. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia. 2015 Mar; 58(3):429-42. PMID: 25583541.
      View in: PubMed
    42. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015 Jan; 38(1):140-9. PMID: 25538310.
      View in: PubMed
    43. Davis AK, DuBose SN, Haller MJ, Miller KM, DiMeglio LA, Bethin KE, Goland RS, Greenberg EM, Liljenquist DR, Ahmann AJ, Marcovina SM, Peters AL, Beck RW, Greenbaum CJ. Prevalence of detectable C-Peptide according to age at diagnosis and duration of type 1 diabetes. Diabetes Care. 2015 Mar; 38(3):476-81. PMID: 25519448.
      View in: PubMed
    44. Lu Y, Pyatak EA, Peters AL, Wood JR, Kipke M, Cohen M, Sequeira PA. Patient perspectives on peer mentoring: type 1 diabetes management in adolescents and young adults. Diabetes Educ. 2015 02; 41(1):59-68. PMID: 25394732.
      View in: PubMed
    45. Stevens GD, Shi L, Vane C, Nie X, Peters AL. Primary care medical home experience and health-related quality of life among adult medicaid patients with type 2 diabetes. J Gen Intern Med. 2015 Feb; 30(2):161-8. PMID: 25316585.
      View in: PubMed
    46. Espeland MA, Glick HA, Bertoni A, Brancati FL, Bray GA, Clark JM, Curtis JM, Egan C, Evans M, Foreyt JP, Ghazarian S, Gregg EW, Hazuda HP, Hill JO, Hire D, Horton ES, Hubbard VS, Jakicic JM, Jeffery RW, Johnson KC, Kahn SE, Killean T, Kitabchi AE, Knowler WC, Kriska A, Lewis CE, Miller M, Montez MG, Murillo A, Nathan DM, Nyenwe E, Patricio J, Peters AL, Pi-Sunyer X, Pownall H, Redmon JB, Rushing J, Ryan DH, Safford M, Tsai AG, Wadden TA, Wing RR, Yanovski SZ, Zhang P. Impact of an intensive lifestyle intervention on use and cost of medical services among overweight and obese adults with type 2 diabetes: the action for health in diabetes. Diabetes Care. 2014 Sep; 37(9):2548-56. PMID: 25147253.
      View in: PubMed
    47. Ruby RJ, Armato JP, Pyke C, Peters AL. GLP-1 provoked severe hypoglycemia in an individual with type 2 diabetes and a benign insulinoma. Diabetes Care. 2014 Aug; 37(8):e177-8. PMID: 25061148.
      View in: PubMed
    48. Lipkin EW, Schwartz AV, Anderson AM, Davis C, Johnson KC, Gregg EW, Bray GA, Berkowitz R, Peters AL, Hodges A, Lewis C, Kahn SE. The Look AHEAD Trial: bone loss at 4-year follow-up in type 2 diabetes. Diabetes Care. 2014 Oct; 37(10):2822-9. PMID: 25048381; PMCID: PMC4170123.
      View in: PubMed, PubMed Central
    49. Wong JC, Foster NC, Maahs DM, Raghinaru D, Bergenstal RM, Ahmann AJ, Peters AL, Bode BW, Aleppo G, Hirsch IB, Kleis L, Chase HP, DuBose SN, Miller KM, Beck RW, Adi S. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry. Diabetes Care. 2014 Oct; 37(10):2702-9. PMID: 25011947; PMCID: PMC4392936.
      View in: PubMed, PubMed Central
    50. Eby EL, Zagar AJ, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA. Healthcare costs and adherence associated with human regular U-500 versus high-dose U-100 insulin in patients with diabetes. Endocr Pract. 2014 Jul; 20(7):663-70. PMID: 24449672.
      View in: PubMed
    51. Chiang JL, Kirkman MS, Laffel LM, Peters AL. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014 Jul; 37(7):2034-54. PMID: 24935775.
      View in: PubMed
    52. Stevens GD, Shi L, Vane C, Peters AL. Do experiences consistent with a medical-home model improve diabetes care measures reported by adult Medicaid patients? Diabetes Care. 2014 Sep; 37(9):2565-71. PMID: 24947789.
      View in: PubMed
    53. Trief PM, Xing D, Foster NC, Maahs DM, Kittelsrud JM, Olson BA, Young LA, Peters AL, Bergenstal RM, Miller KM, Beck RW, Weinstock RS. Depression in adults in the T1D Exchange Clinic Registry. Diabetes Care. 2014 Jun; 37(6):1563-72. PMID: 24855157.
      View in: PubMed
    54. Pyatak EA, Florindez D, Peters AL, Weigensberg MJ. "We are all gonna get diabetic these days": the impact of a living legacy of type 2 diabetes on Hispanic young adults' diabetes care. Diabetes Educ. 2014 Sep-Oct; 40(5):648-58. PMID: 24867918.
      View in: PubMed
    55. Sepah SC, Jiang L, Peters AL. Translating the Diabetes Prevention Program into an Online Social Network: Validation against CDC Standards. Diabetes Educ. 2014 07; 40(4):435-443. PMID: 24723130.
      View in: PubMed
    56. Arora S, Peters AL, Burner E, Lam CN, Menchine M. Trial to examine text message-based mHealth in emergency department patients with diabetes (TExT-MED): a randomized controlled trial. Ann Emerg Med. 2014 Jun; 63(6):745-54.e6. PMID: 24225332.
      View in: PubMed
    57. Jovanovic L, Peters AL, Jiang HH, Hardin DS. Durability of glycemic control with insulin lispro mix 75/25 versus insulin glargine for older patients with type 2 diabetes. Aging Clin Exp Res. 2014 Apr; 26(2):115-21. PMID: 24092662.
      View in: PubMed
    58. Sequeira PA, Montoya L, Ruelas V, Xing D, Chen V, Beck R, Peters AL. Continuous glucose monitoring pilot in low-income type 1 diabetes patients. Diabetes Technol Ther. 2013 Oct; 15(10):855-8. PMID: 23865840.
      View in: PubMed
    59. Weinstock RS, Xing D, Maahs DM, Michels A, Rickels MR, Peters AL, Bergenstal RM, Harris B, Dubose SN, Miller KM, Beck RW. Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab. 2013 Aug; 98(8):3411-9. PMID: 23760624.
      View in: PubMed
    60. Espeland MA, Rejeski WJ, West DS, Bray GA, Clark JM, Peters AL, Chen H, Johnson KC, Horton ES, Hazuda HP. Intensive weight loss intervention in older individuals: results from the Action for Health in Diabetes Type 2 diabetes mellitus trial. J Am Geriatr Soc. 2013 Jun; 61(6):912-22. PMID: 23668423.
      View in: PubMed
    61. Eby EL, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA. Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis. J Med Econ. 2013; 16(4):529-38. PMID: 23363330.
      View in: PubMed
    62. Peters AL. Challenges in applying diabetes technology to clinical care. Diabetes Technol Ther. 2012 Oct; 14(10):849-50. PMID: 23013199.
      View in: PubMed
    63. Best JH, Romley JA, Goldman DP, Conrad RM, Peters AL. Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimens. Am J Manag Care. 2012 Sep; 18(8 Suppl):s191-202. PMID: 23039898.
      View in: PubMed
    64. Romley JA, Goldman DP, Solomon M, McFadden D, Peters AL. Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther. 2012 Oct; 14(10):904-11. PMID: 22845701.
      View in: PubMed
    65. Arora S, Peters AL, Agy C, Menchine M. A mobile health intervention for inner city patients with poorly controlled diabetes: proof-of-concept of the TExT-MED program. Diabetes Technol Ther. 2012 Jun; 14(6):492-6. PMID: 22524591.
      View in: PubMed
    66. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012 Jun; 35(6):1364-79. PMID: 22517736.
      View in: PubMed
    67. Schwartz AV, Johnson KC, Kahn SE, Shepherd JA, Nevitt MC, Peters AL, Walkup MP, Hodges A, Williams CC, Bray GA. Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial. J Bone Miner Res. 2012 Mar; 27(3):619-27. PMID: 22354851; PMCID: PMC3410035.
      View in: PubMed, PubMed Central
    68. Menchine MD, Wiechmann W, Peters AL, Arora S. Trends in diabetes-related visits to US EDs from 1997 to 2007. Am J Emerg Med. 2012 Jun; 30(5):754-8. PMID: 21570241.
      View in: PubMed
    69. Peters A. Incretin-based therapies: review of current clinical trial data. Am J Med. 2010 Mar; 123(3 Suppl):S28-37. PMID: 20206729.
      View in: PubMed
    70. Peters AL. Patient and treatment perspectives: Revisiting the link between type 2 diabetes, weight gain, and cardiovascular risk. Cleve Clin J Med. 2009 Dec; 76 Suppl 5:S20-7. PMID: 19952300.
      View in: PubMed
    71. Cobble ME, Peters AL. Clinical practice in type 2 diabetes: After metformin and lifestyle, then what? J Fam Pract. 2009 Nov; 58(11 Suppl Clinical):S7-14. PMID: 19891948.
      View in: PubMed
    72. Peters A. A piece of my mind. Clinic of tears. JAMA. 2009 Jun 10; 301(22):2309. PMID: 19509369.
      View in: PubMed
    73. Kipke MD, Iverson E, Moore D, Booker C, Ruelas V, Peters AL, Kaufman F. Food and park environments: neighborhood-level risks for childhood obesity in east Los Angeles. J Adolesc Health. 2007 Apr; 40(4):325-33. PMID: 17367725.
      View in: PubMed
    74. Peters AL, Miller D. Case study 2: new insights: clinical pearls for using incretin mimetics in type 2 diabetes. Diabetes Educ. 2007 Jan-Feb; 33 Suppl 1:14S-19S. PMID: 17272804.
      View in: PubMed
    75. Peters AL. Identification of appropriate patients for cardiometabolic risk management. Rev Cardiovasc Med. 2007; 8 Suppl 4:S9-16. PMID: 17934394.
      View in: PubMed
    76. Mathur R, Roybal GM, Peters AL. Short and longer term outcomes of a diabetes disease management program in underserved Latino patients. Curr Med Res Opin. 2005 Dec; 21(12):1935-41. PMID: 16368043.
      View in: PubMed
    Anne's Networks
    Concepts
    Derived automatically from this person's publications.
    See all (260) concept(s)
    _
    Co-Authors
    People in Profiles who have published with this person.
    See all (26) people
    _
    Similar People
    People who share similar concepts with this person.
    See all (59) people
    _
    Same Department
    Search Department
    ↑